Medpace Holdings (MEDP) Gross Profit (2015 - 2026)

Medpace Holdings (MEDP) has reported Gross Profit for 12 consecutive years, with $201.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 12.01% year-over-year to $201.6 million; the trailing twelve-month figure through Jun 2026 stood at $800.2 million (up 13.4% YoY), and the FY2025 full-year result was $760.6 million, up 15.89% from the prior year.
• Gross Profit improved to $201.6 million in Q2 2026 per MEDP's latest filing, from $196.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $205.3 million in Q4 2025 and bottomed at $98.7 million in Q1 2022.
• Historically, Gross Profit has averaged $154.0 million across 5 years, with a median of $154.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Gross Profit soared 36.67% in 2022, then advanced 10.08% in 2026.
• Over 5 years, Gross Profit stood at $115.7 million in 2022, then gained by 18.21% to $136.8 million in 2023, then jumped by 30.34% to $178.3 million in 2024, then climbed by 15.14% to $205.3 million in 2025, then declined by 1.79% to $201.6 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $201.6 million, $196.3 million, and $205.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.